<DOC>
	<DOCNO>NCT02001051</DOCNO>
	<brief_summary>Background : - Adrenal tumor common kind tumor . Some secrete extra cortisol body , lead diabetes , obesity , disease . Some people extra cortisol show symptom like bruise muscle weakness . Others show sign . This call subclinical hypercortisolism . Some adrenal tumor become malignant . Researchers want know best way treat people subclinical hypercortisolism . They want know remove tumor surgery reduce long-term effect disease . Objectives : - To see remove adrenal tumor surgery improve blood pressure , diabetes , obesity , osteoporosis , cholesterol , cancer detection . Eligibility : - Adults 18 old adrenal tumor high cortisol level . Design : - Participants screen medical history , blood test , CT scan . - Participants baseline visit . They blood urine test 7 scan . For scan , substance inject tube arm . Participants lie still table machine take image . - Participants surgery remove tumor . Some surgery right away . Some surgery 6 month later , 2 follow-up appointment . - Participants 4 follow-up visit first year surgery . They 2 visit second year , yearly visit 3 year . At follow-up visit , scan blood test .</brief_summary>
	<brief_title>Study Adrenalectomy Versus Observation Subclinical Hypercortisolism</brief_title>
	<detailed_description>Background : - Adrenal incidentalomas common find approximately 4-7 % population . - About 0.6 25 % patient adrenal incidentaloma find subclinical hypercortisolism : 2.3 % develop subclinical hypercortisolism follow 0.6 % develop clinical hypercortisolism follow . - Subclinical hypercortisolism define biochemical excess cortisol without sign symptom overt hypercortisolism may associate metabolic complication disease progression malignancy . - Overt sign symptom hypercortisolism include facial plethora , easy bruising , violaceous straiae , proximal muscle weakness . - Several study suggest subclinical hypercortisolism may lead long term consequence diabetes , hypertension , hypercholesterolemia , obesity , osteoporosis . - Thus , patient subclinical hypercortisolism may benefit operative intervention halt reverse metabolic complication associate disease risk malignant progression . - The optimal management patient subclinical hypercortisolism adrenal incidentalomas controversial large randomize trial conduct . - We hypothesize operative treatment would reduce risk long term complication subclinical hypercortisolism malignant progression , propose prospective randomize trial compare nonoperative operative management subclinical hypercortisolism patient adrenal neoplasm . Objectives : Primary Endpoints : -To determine whether unilateral adrenalectomy patient diagnose subclinical hypercortisolism adrenal neoplasm result normalization and/or improvement hypertension assess reduction pharmacotherapy and/or normalization blood pressure ( systolic pressure &lt; =140 dias tolic pressure &lt; =90 ) , diabetes assessed reduction elimination pharmacotherapy and/or improvement A1C &lt; 6.5 % , osteoporosis increase bone formation marker indicative increase bone formation , hypercholesterolemia assess reduction elimination pharmacotherapy and/or reduction LDL level risk-stratified goal level define ATP III , and/or overweight obesity assess 10 percent reduction weight 6 month . Eligibility : - An individual adrenal neoplasm le 5 cm size biochemically confirm evidence hypercortisolism ( 2 3 : dexamethasone suppression test ( DST ) &gt; 3 mcgl/dL , elevate urine free cortisol , and/or morning ACTH &lt; 2.2 pmol/l ) without overt clinical sign symptom . - Age great equal 18 year . - Adults must able understand sign inform consent document . - Patients must laboratory physical examination parameter within acceptable limit base standard clinical practice . Design : - Prospective randomize study compare adrenalectomy versus observation . - Patients assign operative arm undergo adrenalectomy follow postoperatively normalization and/or improvement metabolic complication associate hypercortisolism histologic examination resect tumor . - Patients assign non-operative arm monitor possible complication associate hypercortisolism six month , point cross-over operative intervention arm . - Patients bilateral adrenal neoplasm large adrenal neoplasm use primary lesion responsible subclinical hypercortisolism . - Demographic , clinical , laboratory pathologic data collect patient participant . Data securely store computerized database . - Patients biochemical test determine adrenal neoplasm function nonfunctioning . - Projected accrual 15 20 patient per year total 5 year . Thus , anticipate accrue 62 patient protocol .</detailed_description>
	<mesh_term>Cushing Syndrome</mesh_term>
	<mesh_term>Adrenocortical Hyperfunction</mesh_term>
	<criteria>INCLUSION CRITERIA : An individual adrenal neoplasm le 5 cm size biochemically confirm evidence hypercortisolism ( 2 3 : DST &gt; 3 mcgl/dL , elevate urine free cortisol , and/or morning ACTH &lt; 2.2 pmol/l ) without overt clinical sign symptom . Age great equal 18 year . Adults must able understand sign inform consent document . Patients must laboratory physical examination parameter within acceptable limit standard practice . EXCLUSION CRITERIA : Biochemically and/or radiologically confirm pheochromocytoma , hyperaldosteronoma , adrenocortical carcinoma . Nonfunctioning adrenal neoplasm . Preexisting cancer and/or metastatic disease adrenal gland . Pregnancy and/or lactation . Lack metabolic complication . Imaging feature worrisome malignancy ( heterogeneous tumor , presence calcification , necrosis , &gt; 10 Hounsfield unit unenhanced CT scan , delay washout contrast ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 24, 2017</verification_date>
	<keyword>Unilateral Adrenal Neoplasm</keyword>
	<keyword>Cushing Syndrome</keyword>
	<keyword>Adrenal Incidentalomas</keyword>
</DOC>